Bris­tol-My­ers part­ners with Park­er In­sti­tute, CRI on a next-gen twist on trans­la­tion­al R&D

Bris­tol-My­ers Squibb is team­ing up with the grow­ing vir­tu­al net­work of sci­en­tists at the Park­er In­sti­tute for Can­cer Im­munother­a­py to ex­pand its fo­cus on an …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.